Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Evaluation of the 4 Fr. Attain SD Model 4189 left ventricular pacing lead in the Multicenter InSync Randomized Clinical Evaluation in ICD patients (MIRACLE ICD) trial has begun with the implantation of the lead in a 70-year old male at Emory Health Care/Crawford Long Hospital in Atlanta. Billed as the "world's smallest diameter" LV lead, the Attain SD uses electrical conduction and steroid elution technologies to "more easily and quickly position the lead into the lower left chamber of the heart," Medtronic says
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT012615

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel